Liu C, Park Y, Ma C, Stuart C, Gen R, Sun Y
bioRxiv. 2025; .
PMID: 40027745
PMC: 11870458.
DOI: 10.1101/2025.02.19.639017.
Siwak K, LeBlanc E, Scott H, Kim Y, Pellizzari-Delano I, Ball A
PLoS Pathog. 2024; 20(12):e1012365.
PMID: 39625989
PMC: 11642992.
DOI: 10.1371/journal.ppat.1012365.
Stein S, Hansen G, Ssebyatika G, Stroh L, Ochulor O, Herold E
J Virol. 2024; 98(12):e0122324.
PMID: 39494911
PMC: 11650997.
DOI: 10.1128/jvi.01223-24.
Liu P, Huang M, Guo H, McCallum M, Si J, Chen Y
Nature. 2024; 635(8040):978-986.
PMID: 39478224
DOI: 10.1038/s41586-024-08121-5.
Si J, Chen Y, Sun Y, Gu M, Huang M, Shi L
Nat Commun. 2024; 15(1):8869.
PMID: 39402048
PMC: 11473667.
DOI: 10.1038/s41467-024-53029-3.
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses.
Park Y, Liu C, Lee J, Brown J, Ma C, Liu P
bioRxiv. 2024; .
PMID: 39253417
PMC: 11383307.
DOI: 10.1101/2024.08.28.608351.
Development of a SARS-CoV-2 neutralization assay based on a pseudotyped virus using a HIV system.
Liang Z, Tong J, Wu X, Liu S, Wu J, Yu Y
MedComm (2020). 2024; 5(4):e517.
PMID: 38525106
PMC: 10959455.
DOI: 10.1002/mco2.517.
Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector.
Liang Z, Wu X, Wu J, Liu S, Tong J, Li T
Emerg Microbes Infect. 2023; 12(2):e2261566.
PMID: 37727107
PMC: 10540657.
DOI: 10.1080/22221751.2023.2261566.
Active Ingredients of Reduning Injection Maintain High Potency against SARS-CoV-2 Variants.
Xiao Z, Xu H, Qu Z, Ma X, Huang B, Sun M
Chin J Integr Med. 2022; 29(3):205-212.
PMID: 36374439
PMC: 9661462.
DOI: 10.1007/s11655-022-3686-5.
Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, China.
Liu Q, Xiong Q, Mei F, Ma C, Zhang Z, Hu B
Innovation (Camb). 2021; 3(1):100181.
PMID: 34746904
PMC: 8563080.
DOI: 10.1016/j.xinn.2021.100181.
Cell Entry of Animal Coronaviruses.
Cheng Y, Li X, Zhao X, Lin H
Viruses. 2021; 13(10).
PMID: 34696406
PMC: 8540712.
DOI: 10.3390/v13101977.
ACE2 receptor usage reveals variation in susceptibility to SARS-CoV and SARS-CoV-2 infection among bat species.
Yan H, Jiao H, Liu Q, Zhang Z, Xiong Q, Wang B
Nat Ecol Evol. 2021; 5(5):600-608.
PMID: 33649547
DOI: 10.1038/s41559-021-01407-1.
SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus.
Havranek K, Jimenez A, Acciani M, Lay Mendoza M, Reyes Ballista J, Diaz D
Viruses. 2020; 12(12).
PMID: 33353101
PMC: 7767099.
DOI: 10.3390/v12121465.
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.
Xiong H, Wu Y, Cao J, Yang R, Liu Y, Ma J
Emerg Microbes Infect. 2020; 9(1):2105-2113.
PMID: 32893735
PMC: 7534347.
DOI: 10.1080/22221751.2020.1815589.
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays.
Crawford K, Eguia R, Dingens A, Loes A, Malone K, Wolf C
Viruses. 2020; 12(5).
PMID: 32384820
PMC: 7291041.
DOI: 10.3390/v12050513.
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.
Hoffmann M, Kleine-Weber H, Pohlmann S
Mol Cell. 2020; 78(4):779-784.e5.
PMID: 32362314
PMC: 7194065.
DOI: 10.1016/j.molcel.2020.04.022.
Recombinant vesicular stomatitis virus expressing the spike protein of genotype 2b porcine epidemic diarrhea virus: A platform for vaccine development against emerging epidemic isolates.
Ke Y, Yu D, Zhang F, Gao J, Wang X, Fang X
Virology. 2019; 533:77-85.
PMID: 31128495
PMC: 7112030.
DOI: 10.1016/j.virol.2019.05.009.
The detection and phylogenetic analysis of porcine deltacoronavirus from Guangdong Province in Southern China.
Mai K, Feng J, Chen G, Li D, Zhou L, Bai Y
Transbound Emerg Dis. 2017; 65(1):166-173.
PMID: 28345292
PMC: 7169752.
DOI: 10.1111/tbed.12644.
Comparison of lentiviruses pseudotyped with S proteins from coronaviruses and cell tropisms of porcine coronaviruses.
Wang J, Deng F, Ye G, Dong W, Zheng A, He Q
Virol Sin. 2016; 31(1):49-56.
PMID: 26908211
PMC: 7090623.
DOI: 10.1007/s12250-015-3690-4.
Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses.
Hoffmann M, Muller M, Drexler J, Glende J, Erdt M, Gutzkow T
PLoS One. 2013; 8(8):e72942.
PMID: 24023659
PMC: 3758312.
DOI: 10.1371/journal.pone.0072942.